中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共30条，第1-10条 帮助

条数/页： 排序方式：
The reversal of anti-HER2 resistance in advanced HER2-positive breast cancer using apatinib: two cases reports and literature review 期刊论文  OAI收割
TRANSLATIONAL CANCER RESEARCH, 2022
作者:  He, Libin;  Shen, Xiabo;  Liu, Yiyuan;  Gao, Lu;  Wu, Jiayi
  |  收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文  OAI收割
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:  Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei
  |  收藏  |  浏览/下载：42/0  |  提交时间：2020/11/26
Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation 期刊论文  OAI收割
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 5, 页码: 934-948
作者:  Wang, Yu;  Peng, Cheng;  Wang, Guimin;  Xu, Zhijian;  Luo, Yongfeng
  |  收藏  |  浏览/下载：13/0  |  提交时间：2020/07/01
Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors 期刊论文  OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 20, 页码: 9085-9104
作者:  Wang, Yuming;  Li, Lijun;  Fan, Jun;  Dai, Yang;  Jiang, Alan
  |  收藏  |  浏览/下载：29/0  |  提交时间：2019/01/08
Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-l-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 154, 页码: 9-28
作者:  Wei, Manman;  Peng, Xia;  Xing, Li;  Dai, Yang;  Huang, Ruimin
  |  收藏  |  浏览/下载：63/0  |  提交时间：2019/01/08
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFR alpha kinase inhibitor for PDGFR alpha driving chronic eosinophilic leukemia 期刊论文  OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 150, 期号: 无, 页码: 366-384
作者:  Wang, Qiang;  Liu, Feiyang;  Qi, Shuang;  Qi, Ziping;  Yan, Xiao-E.
  |  收藏  |  浏览/下载：62/0  |  提交时间：2019/06/10
PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis 期刊论文  OAI收割
BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140
作者:  Fang, Xiaona;  Xie, Hua;  Luo, Min;  Chen, Zhen;  Wang, Fang
  |  收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor 期刊论文  OAI收割
CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219
作者:  Xie, Chengying;  Wan, Xiaozhe;  Quan, Haitian;  Zheng, Mingyue;  Fu, Li
  |  收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08
Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis 期刊论文  OAI收割
Vascular pharmacology, 2018, 卷号: 101, 页码: 29-37
作者:  Mei, Xiyu;  Zhou, Lingyu;  Zhang, Tianyu;  Lu, Bin;  Sheng, Yuchen
  |  收藏  |  浏览/下载：51/0  |  提交时间：2019/01/08
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors 期刊论文  OAI收割
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 卷号: 9
作者:  Sun, Yongkun;  Niu, Wei;  Du, Feng;  Du, Chunxia;  Li, Shuting
  |  收藏  |  浏览/下载：35/0  |  提交时间：2019/01/08